Itte de Waard‐Siebinga
- Ophthalmology top 2%
- Immunology top 10%
- Molecular Biology
- Oncology
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Martine J. JagerPeter I. SchrierErik H.J. DanenMarieke GriffioenCarina G. J. M. HildersJan L. van DelftBettina E. HansenD. de Wolff–Rouendaal
- Topics
- Immunotherapy and Immune Responses (14 papers)Ocular Oncology and Treatments (6 papers)T-cell and B-cell Immunology (5 papers)
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
Itte de Waard‐Siebinga
19 papers receiving 525 citations
Peers
Comparison fields: 5 of 68
- Ophthalmology 321
- Immunology 259
- Molecular Biology 196
- Oncology 121
- Radiology, Nuclear Medicine and Imaging 56
Countries citing papers authored by Itte de Waard‐Siebinga
This map shows the geographic impact of Itte de Waard‐Siebinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itte de Waard‐Siebinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itte de Waard‐Siebinga more than expected).
Fields of papers citing papers by Itte de Waard‐Siebinga
This network shows the impact of papers produced by Itte de Waard‐Siebinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itte de Waard‐Siebinga. The network helps show where Itte de Waard‐Siebinga may publish in the future.
Co-authorship network of co-authors of Itte de Waard‐Siebinga
This figure shows the co-authorship network connecting the top 25 collaborators of Itte de Waard‐Siebinga. A scholar is included among the top collaborators of Itte de Waard‐Siebinga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Itte de Waard‐Siebinga. Itte de Waard‐Siebinga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 14 | |
| 3 | 8 | |
| 4 | 1 | |
| 5 | 15 | |
| 6 | 39 | |
| 7 | 23 | |
| 8 | Multidrug resistance-related proteins in primary choroidal melanomas and in vitro cell lines. | 16 |
| 9 | 33 | |
| 10 | 9 | |
| 11 | 10 | |
| 12 | 76 | |
| 13 | 22 | |
| 14 | Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas. | 23 |
| 15 | 178 | |
| 16 | 10 | |
| 17 | 23 | |
| 18 | 26 | |
| 19 | 4 |
About Itte de Waard‐Siebinga
Itte de Waard‐Siebinga is a scholar working on Family Practice, Ophthalmology and Immunology, having authored 19 papers that have together received 536 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (14 papers), Ocular Oncology and Treatments (6 papers) and T-cell and B-cell Immunology (5 papers). The work is most often cited by research in Ophthalmology (321 citations), Immunology (259 citations) and Immunology and Allergy (39 citations). Itte de Waard‐Siebinga has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Martine J. Jager, Peter I. Schrier, Erik H.J. Danen, Marieke Griffioen, Carina G. J. M. Hilders, Jan L. van Delft, Bettina E. Hansen, D. de Wolff–Rouendaal, Daniël Blom and Gregorius P. M. Luyten. Their work appears in journals such as International Journal of Cancer, Cancer Letters and British Journal of Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.